Summary
VERBO PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2026 annual accounts show equity of €789,198 and a net result of €10,886. Equity is growing by about 3.7% per year across the filed financial years. Its solvency ranks better than 79% of 383 sector peers (NACE 70, financial year 2026). The company has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
- APOTHEEK TEMPELHOFsubsidiarySourceown accounts 31-03-2026100%
According to the annual accounts to 31-03-2026 of VERBO PHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 1 of 4 Gazette acts processed.